Name: Sunshine Biopharma, Inc. (SBFM) Financial Statements
Creator: FinSpry

Sunshine Biopharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Sunshine Biopharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	34.87	24.09	4.35	0.23	0.07
Cost of Revenue	24.20	15.75	2.65	0.12	0.03
Gross Profit	10.67	8.34	1.70	0.11	0.05
Operating Expenses
Research & Development	0.93	1.86	0.81	0.67	0.00
Selling, General & Administrative	14.94	10.83	9.48	1.87	0.61
Operating Expenses	16.48	13.12	10.37	2.55	0.62
Operating Income	-5.81	-4.79	-8.67	-2.44	-0.58
Other Income/Expense
Interest Income	0.50	0.81	0.52	0.00	0.00
Interest Expense	-0.01	0.14	0.04	0.33	-0.17
Other Income/Expense	0.44	0.00	-18.32	-9.67	0.00
Income
Income Before Tax	-5.37	-4.11	-26.51	-12.44	-2.78
Income Tax Expense	-0.23	0.40	0.23	0.00	0.00
Net Income	-5.13	-4.51	-26.74	-12.44	-2.78
Net Income - Continuous Operations	-5.13	-4.51	-26.74	-12.44	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-5.59	-3.82	-26.45	-12.09	-0.56
EBIT	-5.81	-3.97	-26.47	-12.11	-0.58
Depreciation & Amortization	0.22	0.15	0.03	0.01	0.01
Earnings Per Share
Basic EPS	-7.00	-351.00	-3520.00	-9520.00	-
Diluted EPS	-7.00	-351.00	-3520.00	-9520.00	-
Basic Shares Outstanding	0.70	0.01	0.01	0.00	0.00
Diluted Shares Outstanding	0.70	0.01	0.01	0.00	0.00